|

Azacytidine Clinical Trials

1 actively recruiting trial across 1 location

Also known as: 5-AZC, 5-aza, 5-azacytidine, AZA-CR, Ladakamycin +2 more

Pipeline

Phase 2: 1

Top Sponsors

  • M.D. Anderson Cancer Center1

Indications

  • Hodgkin's Lymphoma1
  • Cancer1

Houston, Texas1 trial

A Phase II Study of the Combination of Azacitidine and Pembrolizumab for Patients Relapsed/Refractory Hodgkin's Lymphoma

MD Anderson Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.